Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 1196: Characterization of ALK splicing isoforms in EML4-ALK-translocated lung cancer.

Lorena F. Pontes, Hiroyuki Yasuda, Pasi A. Jänne, Daniel B. Costa, Susumu Kobayashi

Cancer Res (2013) 73 (8_Supplement): 1196.

https://doi.org/10.1158/1538-7445.AM2013-1196

Published: 15 April 2013

View article titled, Abstract 1196: Characterization of ALK splicing isoforms in EML4-ALK-translocated lung cancer.

Journal Articles

Abstract LB-88: Identification of recurrent oncogenic KIF5B-RET rearrangements in non-small cell lung cancer

Marzia Capelletti, Doron Lipson, Geoff Otto, Roman Yelensky, Dalia Ercan, Jhingook Kim Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-il Park, Jeffrey Ross, Philip J. Stephens, Maureen T. Cronin, Pasi A. Jänne

Cancer Res (2012) 72 (8_Supplement): LB-88.

https://doi.org/10.1158/1538-7445.AM2012-LB-88

Published: 15 April 2012

View article titled, Abstract LB-88: Identification of recurrent oncogenic KIF5B-RET rearrangements in non-small cell lung cancer

Journal Articles

Abstract 1541: Secondary mutations in ALK and resistance to ALK kinase inhibitors

Takaaki Sasaki, Katsuhiro Okuda, Wei Zheng, James Butrynski, Marzia Capelletti, Liping Wang, Nathanael Gray, Keith D. Wilner, James G. Christensen, George D. Demetri, Geoffrey I. Shapiro, Scott J. Rodig, Michael J. Eck, Pasi A. Jänne

Cancer Res (2011) 71 (8_Supplement): 1541.

https://doi.org/10.1158/1538-7445.AM2011-1541

Published: 15 April 2011

View article titled, Abstract 1541: Secondary mutations in ALK and resistance to ALK kinase inhibitors

Journal Articles

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib

Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, Eugene Lifshits, Andrea J. Gonzales, Takeshi Shimamura, Feng Zhao, Patrick W. Vincent, George N. Naumov, James E. Bradner, Irene W. Althaus, Leena Gandhi, Geoffrey I. Shapiro, James M. Nelson, John V. Heymach, Matthew Meyerson, Kwok-Kin Wong, Pasi A. Jänne

Cancer Res (2007) 67 (24): 11924–11932.

https://doi.org/10.1158/0008-5472.CAN-07-1885

Published: 18 December 2007

View article titled, PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib

Includes: Supplementary data

Journal Articles

Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Cancer Res (2007) 67 (10): 4933–4939.

https://doi.org/10.1158/0008-5472.CAN-06-4592

Published: 17 May 2007

View article titled, Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Includes: Supplementary data

Journal Articles

Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression

Jingrui Jiang, Heidi Greulich, Pasi A. Jänne, William R. Sellers, Matthew Meyerson, James D. Griffin

Cancer Res (2005) 65 (19): 8968–8974.

https://doi.org/10.1158/0008-5472.CAN-05-1829

Published: 03 October 2005

View article titled, Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression

Journal Articles

Epidermal Growth Factor Receptor Mutations in Patients with Non–Small Cell Lung Cancer

Bruce E. Johnson, Pasi A. Jänne

Cancer Res (2005) 65 (17): 7525–7529.

https://doi.org/10.1158/0008-5472.CAN-05-1257

Published: 01 September 2005

View article titled, Epidermal Growth Factor Receptor Mutations in Patients with Non–Small Cell Lung Cancer

Journal Articles

Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis

Cancer Res (2005) 65 (13): 5561–5570.

https://doi.org/10.1158/0008-5472.CAN-04-4603

Published: 01 July 2005

View article titled, Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis

Includes: Supplementary data

Journal Articles

Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC)

Toru Mukohara, Jeffrey A. Engelman, Neal Lindeman, Balazs Halmos, Bruce E. Johnson, Pasi A. Jänne

Cancer Res (2005) 65 (9_Supplement): 508.

Published: 01 May 2005

View article titled, Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC)

Journal Articles

In-vitro effects of pemetrexed on bronchioloalveolar and adenocarcinoma of the lung

Sean Tracy, Bruce E. Johnson, Pasi A. Jänne

Cancer Res (2005) 65 (9_Supplement): 1380.

Published: 01 May 2005

View article titled, In-vitro effects of pemetrexed on bronchioloalveolar and adenocarcinoma of the lung

Journal Articles

Gefitinib Induces Apoptosis in the EGFR^L858R Non–Small-Cell Lung Cancer Cell Line H3255

Sean Tracy, Toru Mukohara, Mark Hansen, Matthew Meyerson, Bruce E. Johnson, Pasi A. Jänne

Cancer Res (2004) 64 (20): 7241–7244.

https://doi.org/10.1158/0008-5472.CAN-04-1905

Published: 15 October 2004

View article titled, Gefitinib Induces Apoptosis in the EGFRL858R Non–Small-Cell Lung Cancer Cell Line H3255

Journal Articles

An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Xiaojun Zhao, Cheng Li, J. Guillermo Paez, Koei Chin, Pasi A. Jänne, Tzu-Hsiu Chen, Luc Girard, John Minna, David Christiani, Chris Leo, Joe W. Gray, William R. Sellers, Matthew Meyerson

Cancer Res (2004) 64 (9): 3060–3071.

https://doi.org/10.1158/0008-5472.CAN-03-3308

Published: 03 May 2004

View article titled, An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Includes: Supplementary data

Journal Articles

Therapeutic targeting of multiple signaling pathways in mesothelioma

Toru Mukohara, Gabriel Civiello, Bruce E. Johnson, Pasi A. Jänne

Cancer Res (2004) 64 (7_Supplement): 1050.

Published: 01 April 2004

View article titled, Therapeutic targeting of multiple signaling pathways in mesothelioma

Journal Articles

Inhibition of Epidermal Growth Factor Receptor Signaling in Malignant Pleural Mesothelioma

Pasi A. Jänne, Michele L. Taffaro, Ravi Salgia, Bruce E. Johnson

Cancer Res (2002) 62 (18): 5242–5247.

Published: 15 September 2002

View article titled, Inhibition of Epidermal Growth Factor Receptor Signaling in Malignant Pleural Mesothelioma

NARROW

Abstract 1196: Characterization of ALK splicing isoforms in EML4-ALK-translocated lung cancer.

Abstract LB-88: Identification of recurrent oncogenic KIF5B-RET rearrangements in non-small cell lung cancer

Abstract 1541: Secondary mutations in ALK and resistance to ALK kinase inhibitors

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib

Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models

Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression

Epidermal Growth Factor Receptor Mutations in Patients with Non–Small Cell Lung Cancer

Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis

Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers (NSCLC)

In-vitro effects of pemetrexed on bronchioloalveolar and adenocarcinoma of the lung

Gefitinib Induces Apoptosis in the EGFR^L858R Non–Small-Cell Lung Cancer Cell Line H3255

An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays

Therapeutic targeting of multiple signaling pathways in mesothelioma

Inhibition of Epidermal Growth Factor Receptor Signaling in Malignant Pleural Mesothelioma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only